MarketPeel
Insider Trading Intelligence
AV

Akshay Vaishnaw

SRRK
PRESIDENT OF R&D · SCHOLAR ROCK HOLDING CORP · CIK 0001458494
FILING MIX · LIFETIME36%/64%
BUYS
46
SELLS
82
TOTAL VALUE
$32.02M
COMPANIES
3
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
679,733
AVG SELL PX
$144.30
TRADE KIND
SHOWING 128 / 128
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
55 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Akshay Vaishnaw, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d55+49.09%-2.20%+0.19%-2.39%+0.37%-2.19
14d55+70.91%-7.64%-0.10%-7.54%-3.46%-5.31
30d55+65.45%-9.45%-1.92%-7.53%-5.81%-4.69
60d55+76.36%-5.71%-1.35%-4.35%-7.39%-2.13
90d55(1 pending)+74.07%-2.70%+0.97%-3.67%-11.06%-1.78
180d55(2 pending)+75.47%-4.48%+0.76%-5.24%-8.76%-1.66
1y55(2 pending)+22.64%+15.52%+8.16%+5.23%+16.03%1.07
2y55(4 pending)+45.10%+28.46%+20.54%+7.92%-5.55%1.54
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SRRK · 630,542 shares · as of Apr 16, 2026
0160,697321,394482,091642,788202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 46 buys / 82 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
President of R&D
12,246$49.57$607.1K630,542Apr 16, 2026Apr 20, 2026View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
47,021642,788Feb 9, 2026Feb 11, 2026View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
President of R&D
20,438$42.70$872.7K595,767Jan 13, 2026Jan 15, 2026View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE10b5-1
10b5-1 plan
1,620$30.01$48.6K616,205May 29, 2025May 30, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE10b5-1
10b5-1 plan
5,130$29.63$152.0K617,825May 29, 2025May 30, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
110,067110,067May 2, 2025May 6, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
100,000122,955Apr 27, 2025Apr 29, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
500,000622,955Apr 27, 2025Apr 29, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
13,50022,955Jun 27, 2024Jul 1, 2024View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
18,00018,000Jun 27, 2024Jul 1, 2024View →
EDIT
EDITAS MEDICINE, INC.
PURCHASEGRANT
Stock grant
25,00025,000May 30, 2024Jun 3, 2024View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
101$187.37$18.9K22,983Aug 4, 2023Aug 7, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
1,107$186.39$206.3K23,084Aug 4, 2023Aug 7, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
192$189.31$36.3K22,774Aug 4, 2023Aug 7, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
17$188.40$3.2K22,966Aug 4, 2023Aug 7, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
771$184.70$142.4K26,060Aug 4, 2023Aug 7, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
1,869$185.54$346.8K24,191Aug 4, 2023Aug 7, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,08222,972Aug 3, 2023Aug 7, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,85926,831Aug 3, 2023Aug 7, 2023View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
36,00036,000Jun 21, 2023Jun 22, 2023View →
EDIT
EDITAS MEDICINE, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 1, 2023Jun 5, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
168$197.08$33.1K17,890Apr 27, 2023Apr 28, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
197$193.18$38.1K20,085Apr 27, 2023Apr 28, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
910$193.93$176.5K19,175Apr 27, 2023Apr 28, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
104$195.65$20.3K18,058Apr 27, 2023Apr 28, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
1,013$194.94$197.5K18,162Apr 27, 2023Apr 28, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,31220,282Apr 26, 2023Apr 28, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,7905,790Feb 27, 2023Mar 1, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
11,98611,986Feb 27, 2023Mar 1, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
4,302$217.05$933.7K14,970Feb 10, 2023Feb 14, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
1,709$213.13$364.2K51,305Feb 10, 2023Feb 14, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President
30,913$63.00$1.95M53,014Feb 10, 2023Feb 14, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
10,279$215.59$2.22M38,719Feb 10, 2023Feb 14, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
30,9130Feb 10, 2023Feb 14, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
19,447$216.38$4.21M19,272Feb 10, 2023Feb 14, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
2,307$214.28$494.3K48,998Feb 10, 2023Feb 14, 2023View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
1,12428,876Dec 5, 2022Dec 7, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
1,324$226.20$299.5K22,101Dec 5, 2022Dec 7, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
2,3680Dec 5, 2022Dec 7, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President
1,124$88.95$100.0K19,470Dec 5, 2022Dec 7, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President
1,587$63.00$100.0K21,057Dec 5, 2022Dec 7, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President
2,368$42.22$100.0K23,425Dec 5, 2022Dec 7, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
1,58730,913Dec 5, 2022Dec 7, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
195$210.22$41.0K18,724Aug 4, 2022Aug 5, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
180$210.66$37.9K18,544Aug 4, 2022Aug 5, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
198$210.75$41.7K18,346Aug 4, 2022Aug 5, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President
5,479$189.76$1.04M18,919Aug 4, 2022Aug 5, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,08316,298Aug 3, 2022Aug 5, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,85924,398Aug 3, 2022Aug 5, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,24120,539Aug 3, 2022Aug 5, 2022View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
14,00014,000Jun 16, 2022Jun 21, 2022View →
EDIT
EDITAS MEDICINE, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 9, 2022Jun 13, 2022View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
28,00028,000May 26, 2022May 27, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
29,84229,842Feb 23, 2022Feb 25, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
22,38022,380Dec 31, 2021Jan 4, 2022View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
145$193.67$28.1K11,518Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
1,000$191.45$191.4K11,862Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
5$190.27$95113,202Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
142$190.39$27.0K12,987Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
73$192.25$14.0K11,789Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
126$193.37$24.4K11,663Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
127$188.26$23.9K13,576Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
144$190.02$27.4K13,207Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
8$189.18$1.5K13,495Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
137$187.08$25.6K13,833Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
144$189.24$27.3K13,351Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
125$190.86$23.9K12,862Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
130$187.35$24.4K13,703Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
303$195.11$59.1K11,215Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
73$190.33$13.9K13,129Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
124$186.22$23.1K13,970Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
73$189.01$13.8K13,503Dec 23, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
2,415$189.13$456.7K14,217Dec 22, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
122$186.48$22.8K14,094Dec 22, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
1$190.50$19114,216Dec 22, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,41716,632Dec 21, 2021Dec 23, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
10,834$200.00$2.17M11,215Aug 9, 2021Aug 11, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President, R&D
10,834$63.00$682.5K22,049Aug 9, 2021Aug 11, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
10,83410,832Aug 9, 2021Aug 11, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President, R&D
10,834$63.00$682.5K24,953Jun 18, 2021Jun 22, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President, R&D
970$42.22$41.0K25,923Jun 18, 2021Jun 22, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
9702,368Jun 18, 2021Jun 22, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
10,83421,666Jun 18, 2021Jun 22, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
14,708$175.00$2.57M11,215Jun 18, 2021Jun 22, 2021View →
EDIT
EDITAS MEDICINE, INC.
PURCHASEGRANT
Stock grant
11,53811,538Jun 3, 2021Jun 7, 2021View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
7,8007,800May 27, 2021Jun 1, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
107$138.48$14.8K14,119Apr 21, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
530$137.60$72.9K14,226Apr 21, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
203$135.41$27.5K16,648Apr 21, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
1,892$136.84$258.9K14,756Apr 21, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
2,266$131.75$298.5K16,936Apr 20, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
85$134.56$11.4K16,851Apr 20, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,08322,908Apr 19, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
417$140.02$58.4K19,202Apr 19, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
622$138.64$86.2K19,619Apr 19, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
989$137.60$136.1K20,241Apr 19, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
1,678$136.76$229.5K21,230Apr 19, 2021Apr 21, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
28,80028,800Feb 24, 2021Feb 26, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
1,618$156.00$252.4K17,917Feb 12, 2021Feb 16, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
92$152.53$14.0K17,825Feb 12, 2021Feb 16, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,41619,535Feb 11, 2021Feb 16, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
8,33425,000Feb 11, 2021Feb 16, 2021View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
971$140.00$135.9K14,119Sep 29, 2020Oct 1, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President, R&D
971$42.22$41.0K15,090Sep 29, 2020Oct 1, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
9713,338Sep 29, 2020Oct 1, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
178$148.48$26.4K14,911Jun 22, 2020Jun 24, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
83$149.09$12.4K14,828Jun 22, 2020Jun 24, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
180$150.34$27.1K14,648Jun 22, 2020Jun 24, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
9704,309Jun 22, 2020Jun 24, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President, R&D
970$42.22$41.0K15,089Jun 22, 2020Jun 24, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
195$152.97$29.8K14,119Jun 22, 2020Jun 24, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
334$152.22$50.8K14,314Jun 22, 2020Jun 24, 2020View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
13,00013,000Jun 16, 2020Jun 18, 2020View →
EDIT
EDITAS MEDICINE, INC.
PURCHASEGRANT
Stock grant
11,53811,538Jun 10, 2020Jun 12, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
21,0000Apr 20, 2020Apr 22, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President, R&D
21,000$42.22$886.6K35,119Apr 20, 2020Apr 22, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
21,971$140.00$3.08M14,119Apr 20, 2020Apr 22, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President, R&D
971$42.22$41.0K36,090Apr 20, 2020Apr 22, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
9715,279Apr 20, 2020Apr 22, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
98$106.52$10.4K14,119Apr 7, 2020Apr 9, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
2,415$104.75$253.0K14,217Apr 7, 2020Apr 9, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,41716,632Apr 7, 2020Apr 9, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
27,62327,623Feb 26, 2020Feb 28, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
4,00021,000Feb 7, 2020Feb 11, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President, R&D
4,000$42.22$168.9K34,923Feb 7, 2020Feb 11, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
23,708$125.00$2.96M11,215Feb 7, 2020Feb 11, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
President, R&D
18,750$42.22$791.6K30,923Feb 7, 2020Feb 11, 2020View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
President, R&D
18,7506,250Feb 7, 2020Feb 11, 2020View →
Other insiders · SRRK
Loading peer insiders…
About this filer
CIK 0001458494
ROLE
President of R&D
PRIMARY
SRRK
COMPANIES
3
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001458494DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback